nemene AI

nemene AI is a biotechnology company pioneering the discovery of eIF biomarker relationships by using GenAI Discovery. Founded by leading scientists and AI experts, nemene AI aspires to make people live better and longer by bringing medical research results directly to the service of patients. Nemene‘s pipeline consists of severity diagnostics solutions for cancer, neurodegenerative diseases and viral infections. Since nemene’s foundation in 2021, strong partnerships with industry leaders in diagnostics has been established to ensure scalability of the pipeline. To learn more about nemene reach out to us: Info@nemene.ai